InsuranceDekho IPO Plans Take Shape: What We Know So Far
InsuranceDekho’s parent has picked banks for a potential IPO worth up to $400 million. Here’s what’s confirmed so far, including the RenewBuy merger and DRHP timeline.
InsuranceDekho is preparing for a potential initial public offering as the insurtech platform strengthens its market position, expands distribution, and evaluates the timing of its public market debut.
InsuranceDekho IPO: InsuranceDekho is moving closer to the stock market. Its parent company has picked banks for a potential IPO. That is usually the first real sign a listing is coming. Here is everything confirmed so far. Bloomberg reported the news on 7 July 2026. Girnar Insurance Brokers, InsuranceDekho’s parent, has selected four advisers. They are HSBC, Morgan Stanley, ICICI Securities and IIFL Capital Services. Choosing banks is a concrete step. It signals the IPO process has actually started.
InsuranceDekho’s IPO – The Target: Up to $400 Million
Sources say the offering could raise as much as 400 million dollars. A launch is expected later in 2026 or early 2027. The structure will likely include two parts. One is a fresh issue of new shares. The other is a sale of shares by existing investors seeking an exit. Size, timing and valuation are still being worked out. All of it could change with market conditions.
Also Read: Haaland vs Kane: The Hidden $7.5 Million Insurance Policy Protecting Norway vs England Stars
InsuranceDekho IPO: The Ambition Has Grown
This number was smaller just months ago. In February 2026, reports pointed to a 250 million dollar target. That is a jump of roughly 60 percent in five months. It suggests growing confidence, both internal and from investors.
Who Is InsuranceDekho
InsuranceDekho was founded in 2016. It is based in Gurugram. The platform lets customers compare and buy life, health, motor and travel insurance. It has raised about 358 million dollars to date. Backers include TVS Capital Funds, Investcorp and BNP Paribas Cardif.
The RenewBuy Merger Matters Too
InsuranceDekho is also merging with RenewBuy. RenewBuy brings an agency-led distribution network. The merger is expected to close soon. Founder Ankit Agrawal and RenewBuy COO Indraneel Chatterjee have both spoken about the timeline. A draft prospectus, the DRHP, is expected by the end of September 2026. The listing itself is targeted before 31 March 2027.
Two Numbers, One Story
Reports around the merger mention a different figure. They point to a raise of 3,500 to 4,000 crore rupees. That is roughly in line with the 400 million dollar target. The numbers come from different moments in the process. They are not two separate confirmed targets.
The Corporate Structure Behind It
There is a legal restructuring happening in parallel. In November 2025, the Competition Commission of India approved a merger. It combined Girnar Finserv, Girnar Insurance, D2C Consulting Services and RB Info Services. The new entity is called Artivatic Data Labs. It now sits behind the InsuranceDekho platform.
Why the Merger Makes Sense
The logic is simple. InsuranceDekho is strong in digital-first distribution. RenewBuy is strong in agent-led sales. Combined, they cover more ground. Both companies have flagged Tier II and Tier III cities as a priority. That is where much of India’s insurance growth is expected to come from.
The Market Backdrop
India’s IPO market has been slow in 2026. Companies raised about 3.9 billion dollars in the first half. That is down sharply from 22 billion dollars a year earlier. Even so, big listings are reportedly coming. Jio Platforms, the National Stock Exchange of India, SBI Funds Management and Manipal Health Enterprises are all in the pipeline. Bankers expect a busier second half of the year.
What’s Still Missing
No prospectus has been filed yet. No valuation has been confirmed. InsuranceDekho has not commented publicly on the reports.
The Bottom Line
The pieces are lining up. Banks are mandated. The RenewBuy merger is closing. A DRHP deadline is set. Together, they point to a real IPO within the next twelve months. This is one insurtech story worth watching closely through the rest of 2026.
